Replimune Group, Inc.·4

May 20, 4:16 PM ET

Sarchi Christopher 4

Research Summary

AI-generated summary

Updated

Replimune (REPL) CCO Christopher Sarchi Sells 8,626 Shares

What Happened

  • Christopher Sarchi, Chief Commercial Officer of Replimune Group, sold 8,626 shares of REPL on 2026-05-18 in transactions totaling approximately $43,820. The reported weighted-average price was $5.08 per share, with individual sales ranging from $5.02 to $5.08.
  • This was a sale to satisfy tax withholding obligations tied to the partial vesting of Restricted Stock Units (RSUs), not a discretionary open-market sell for investment reasons.

Key Details

  • Transaction date: 2026-05-18; filing date: 2026-05-20 (appears timely; Form 4 is generally due within two business days).
  • Price: weighted average $5.08; per-share range $5.02–$5.08 (sold in multiple transactions).
  • Shares disposed: 8,626; proceeds ≈ $43,820.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnotes: F1 — sale was a mandatory "sell to cover" for tax withholding on RSU vesting (not a discretionary sale). F2 — price is a weighted average; the filer can provide a breakdown of how many shares sold at each price on request.
  • Transaction code: S (sale); tax-withholding implication (commonly reported as withholding-related disposition).

Context

  • "Sell to cover" transactions are routine when RSUs vest and generally reflect tax liability rather than a judgment about the company's outlook. Such transactions are considered less informative about insider sentiment than voluntary, discretionary sales or purchases.
  • If you want the exact per-trade breakdown within the $5.02–$5.08 range, the filing notes the reporting person can provide those details upon request.